Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1101P (RNA, U6 small nuclear 1101, pseudogene) refers to a processed pseudogene derived from the U6 small nuclear RNA gene, present in the human genome as a non-protein encoding locus[4]. The U6 snRNA itself is a highly conserved, non-coding RNA component of the spliceosome, responsible for catalyzing intron excision from pre-mRNA as part of post-transcriptional mRNA maturation[3][1][5]. By contrast, pseudogenes like RNU6-1101P are generated via retrotransposition events by LINE elements such as LINE-1, and do not produce a functional RNA product[2]. These pseudogenes may serve as markers of genome retrotransposition history but lack any direct biological function or disease relevance, and are not considered receptors, enzymes, therapeutic targets, or useful biomarkers[2][4][3].
Not applicable; pseudogenes do not encode proteins or functional RNA and therefore do not participate in druggable mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1101, pseudogene (RNU6-1101P).